Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ENDY.TADELISTED
- Price
- -
- Stock movement up
- +- (0.00%)
- Company name
- Endymed
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Medical Devices
- Market cap
- 4.41B
- Ent value
- 4.40B
- Price/Sales
- 224.71
- Price/Book
- 300.27
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -22.85%
- 1 year return (CAGR)
- -1.51%
- 3 year return (CAGR)
- -27.06%
- 5 year return (CAGR)
- 7.81%
- 10 year return (CAGR)
- -35.46%
Last updated: 2025-09-16
DIVIDENDS
ENDY.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 224.71 |
| Price to Book | 300.27 |
| EV to Sales | 224.59 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 13.76M |
| EPS (TTM) | -0.06 |
| FCF per share (TTM) | -0.24 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 19.60M |
| Gross profit (TTM) | 9.74M |
| Operating income (TTM) | -1.00M |
| Net income (TTM) | -835.00K |
| EPS (TTM) | -0.06 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 49.68% |
| Operating margin (TTM) | -5.12% |
| Profit margin (TTM) | -4.26% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 7.36M |
| Net receivables | 1.58M |
| Total current assets | 16.43M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 1.44M |
| Total assets | 19.57M |
| Accounts payable | 1.54M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.66M |
| Total liabilities | 4.90M |
| Shareholder's equity | 14.67M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.21M |
| Capital expenditures (TTM) | 75.00K |
| Free cash flow (TTM) | -3.28M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -5.69% |
| Return on Assets | -4.27% |
| Return on Invested Capital | -5.69% |
| Cash Return on Invested Capital | -22.37% |
STOCK INFORMATION
Stock chart
No data
Stock price data
| Open | 320.10 |
| Daily high | 320.10 |
| Daily low | 320.10 |
| Daily Volume | 2K |
| 1y analyst estimate | - |
| Beta | -0.29 |
| EPS (TTM) | -0.06 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ENDY.TA | S&P500 | |
| Current price drop from All-time high | -99.79% | -0.00% |
| Highest price drop | -99.91% | -56.47% |
| Date of highest drop | 14 May 2018 | 9 Mar 2009 |
| Avg drop from high | -85.39% | -10.84% |
| Avg time to new high | 492 days | 12 days |
| Max time to new high | 4309 days | 1805 days |
COMPANY DETAILS
Marketcap
4.41B
Marketcap category
Mid-cap
Description
Endymed Ltd provides energy based medical aesthetic treatment systems for the professional and consumer markets in North America, Europe, the Middle East, Africa, Asia, Oceania, Latin America, and internationally. The company offers ENDYMED PRO, an all-in-one treatment platform; ENDYMED PURE 2.0, a compact and flexible treatment platform; Pure Laser, a laser hair removal system; Intensif, a RF microneedle technology; FSR, a skin resurfacing tool; Focused RF, which uses 3DEEP tightening and contouring handpieces for the face, neck, and body; NEWA, a home use device for facial tightening and lifting; and ENDYMED Contour to fight stubborn cellulite. Its products provide treatments for acne scar removal, body tightening, cellulite reduction, eye lift, jawline and neck tightening, facial tightening, fractional skin resurfacing, and scar and stretchmark reduction. Endymed Ltd is based in Caesarea, Israel.
Employees
46
Website
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found